Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Gene Families

Gene Families

Gene families consist of groups of genes proposed to have originated from a common ancestor. Typically these arise through events in which a gene or genes are mistakenly duplicated during cell division. Unlike their parent genes (which are subject to selection pressure to maintain function), these gene copies do not need to preserve their sequences and may evolve at a relatively faster rate.
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...

Structure and Function of Erythrocytes

Structure and Function of Erythrocytes

There are between 4.2 and 6 million erythrocytes, also known as red blood cells, in every microliter of blood. These cells are small, flattened biconcave discs with centers that are depressed.
The erythrocyte plasma membrane is associated with proteins such as spectrin, which forms a flexible cytoplasmic meshwork. This meshwork allows erythrocytes to twist, turn, become cup-shaped, and regain their biconcave shape as they pass through narrow capillaries. Additionally, erythrocytes can form...

Globular and Fibrous Proteins

Globular and Fibrous Proteins

Many proteins can be classified into two distinct subtypes - globular or fibrous. These two types differ in their shapes and solubilities.
Globular proteins are also known as spheroproteins and typically are approximately round in shape. They contain a mix of amino acid types and contain differing sequences in their primary structures. Globular proteins have many different functions, such as enzymes, cellular messengers, and molecular transporters. These roles often require the proteins to be...

The Early Endosome: Endocytosis of Transferrin

The Early Endosome: Endocytosis of Transferrin

Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...

Hemoglobin

Hemoglobin

Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A Non-Invasive Combined Photothermal-Sonodynamic Therapy Using a Dual-Activated TiO<sub>2</sub>-Au Nanohybrid: A Competitive Alternative to the Invasive Radiotherapy.

Ultrasound in medicine & biology·2026

Same author

Direct detection of unamplified DNA from Mycobacterium tuberculosis using modified gold nanoparticles.

Diagnostic microbiology and infectious disease·2026

Same author

Selenium-Curcumin-PEG Nanoparticles Radiosensitization for Intensity-Modulated Radiation Therapy of Lung Tumor Cells: <i>In Vitro</i> Synergistic Combination Therapy.

Journal of biomedical physics & engineering·2026

Same author

Enhancing curcumin bioavailability using bifunctional periodic mesoporous organosilica for pH-responsive anticancer drug delivery.

Nanomedicine : nanotechnology, biology, and medicine·2026

Same author

Ligand tricks for faster clicks: bioconjugation <i>via</i> the CuAAC reaction.

Chemical communications (Cambridge, England)·2025

Same author

Visual and spectrophotometric nanobiosensor for <i>Leishmania infantum</i> detection based on kinetoplast DNA probe.

Journal of parasitic diseases : official organ of the Indian Society for Parasitology·2025

Search research articles

Related Experiment Video

Updated: May 18, 2026

Labeling Stem Cells with Ferumoxytol, an FDA-Approved Iron Oxide Nanoparticle

Labeling Stem Cells with Ferumoxytol, an FDA-Approved Iron Oxide Nanoparticle

Published on: November 4, 2011

Desferal as improving agent for hemoglobin fructation: structural and functional impacts.

Naghmeh Sattarahmady¹, Hossein Heli, Ali A Moosavi-Movahedi

¹Department of Medical Physics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. sattarahmady@yahoo.com

The Protein Journal

|September 27, 2012

Summary

Desferal, an iron chelator, shows significant anti-glycation properties by protecting hemoglobin from damage during the fructation process. This suggests its potential as a therapeutic agent to prevent advanced glycation end product formation in diabetic patients.

More Related Videos

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Published on: February 23, 2024

Revealing the Ferroptotic Phenotype of Medulloblastoma

Revealing the Ferroptotic Phenotype of Medulloblastoma

Published on: March 15, 2024

Related Experiment Videos

Last Updated: May 18, 2026

Labeling Stem Cells with Ferumoxytol, an FDA-Approved Iron Oxide Nanoparticle

Labeling Stem Cells with Ferumoxytol, an FDA-Approved Iron Oxide Nanoparticle

Published on: November 4, 2011

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Published on: February 23, 2024

Revealing the Ferroptotic Phenotype of Medulloblastoma

Revealing the Ferroptotic Phenotype of Medulloblastoma

Published on: March 15, 2024

Area of Science:

Biochemistry
Pharmacology
Diabetology

Background:

Hyperglycemia and advanced glycation end products (AGEs) contribute to diabetic complications.
Identifying compounds with anti-glycation properties is crucial for therapeutic development.
Hemoglobin (Hb) fructation is a marker of glycemic control and oxidative stress.

Purpose of the Study:

To investigate the potential anti-glycation effects of desferal, an iron chelator.
To evaluate desferal's impact on the structural and functional changes of hemoglobin during fructation.
To determine if desferal can prevent the formation of AGEs and preserve Hb activity.

Main Methods:

Incubation of hemoglobin (Hb) with glucose to induce fructation.
Treatment of fructated Hb with desferal.
Assessment of structural changes (e.g., helix depletion) and AGE formation.
Evaluation of peroxidase and esterase activities of native, fructated, and desferal-treated Hb.

Main Results:

Desferal demonstrated a significant retardation effect on Hb fructation.
Desferal inhibited the formation of AGEs and carbonyl groups in Hb.
Desferal prevented helix depletion in fructated Hb.
Desferal preserved the peroxidase and esterase activities of fructated Hb, similar to native Hb.

Conclusions:

Desferal exhibits notable anti-glycation properties.
Desferal protects hemoglobin from structural and functional damage induced by fructation.
Desferal can be considered a potential anti-glycation drug for preventing AGE formation in conditions like diabetes.